Science News
from research organizations

Potential new targets for treating kidney disease

Proteins in the Wnt signaling pathway play a critical role in kidney scarring

Date:
July 23, 2015
Source:
American Society of Nephrology
Summary:
Proteins in the Wnt signaling pathway help drive kidney scarring that can lead to chronic kidney disease, researchers report. When investigators examined the complex process of scarring, or fibrosis, in failing kidneys, they discovered that proteins in the Wnt signaling pathway play a critical role in the crosstalk between cells as scarring occurs.
Share:
FULL STORY

Chronic diseases such as diabetes and hypertension cause injury to the kidneys, which can lead to scarring and the development of chronic kidney disease. By identifying proteins important to this scarring process, researchers now point to a new strategy for possibly preventing kidney failure and the need for dialysis or transplantation in many patients. The findings appear in an upcoming issue of the Journal of the American Society of Nephrology (JASN).

When Benjamin Humphreys MD, PhD (Washington University School of Medicine) and his colleagues examined the complex process of scarring, or fibrosis, in failing kidneys, they discovered that proteins in the Wnt signaling pathway play a critical role in the crosstalk between cells as scarring occurs. Wnt proteins are important in development but are normally turned off in healthy kidneys. When the researchers boosted expression of Wnt proteins in the kidneys of healthy mice, the organs developed fibrosis. "This means that drugs targeting Wnts might be an effective strategy for humans with chronic kidney disease," said Dr. Humphreys.

The investigators were surprised to find that Wnt proteins cause kidney fibrosis without inflammation. "In the models we typically use to study in the laboratory, and also in human fibrosis, there is always some degree of inflammation, so to not find any was unexpected," explained Dr. Humphreys. "We conclude that inflammation is not required for the development of kidney fibrosis, and this suggests that purely anti-inflammatory drugs may not be as effective at treating chronic kidney disease.


Story Source:

Materials provided by American Society of Nephrology. Note: Content may be edited for style and length.


Journal Reference:

  1. Omar Maarouf, MD, Anusha Aravamudhan, BS, Deepika Rangarajan, BS, Tetsuro Kusaba, MD, Victor Zhang, Jeremy Welborn, Daniel Gauvin, BS, Xiuyun Hou, PhD, and Rafael Kramann, MD. Paracrine Wnt1 Drives Interstitial Fibrosis without Inflammation by Tubulointerstitial Cross-Talk. Journal of the American Society of Nephrology, July 2015 DOI: 10.1681/ASN.2014121188

Cite This Page:

American Society of Nephrology. "Potential new targets for treating kidney disease: Proteins in the Wnt signaling pathway play a critical role in kidney scarring." ScienceDaily. ScienceDaily, 23 July 2015. <www.sciencedaily.com/releases/2015/07/150723181105.htm>.
American Society of Nephrology. (2015, July 23). Potential new targets for treating kidney disease: Proteins in the Wnt signaling pathway play a critical role in kidney scarring. ScienceDaily. Retrieved May 23, 2017 from www.sciencedaily.com/releases/2015/07/150723181105.htm
American Society of Nephrology. "Potential new targets for treating kidney disease: Proteins in the Wnt signaling pathway play a critical role in kidney scarring." ScienceDaily. www.sciencedaily.com/releases/2015/07/150723181105.htm (accessed May 23, 2017).

RELATED STORIES